- Home
- PG vs MRK Comparison
PG vs MRK Comparison
Compare PG & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PG | MRK |
|---|---|---|
| Founded | 1837 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 334.3B | 268.7B |
| IPO Year | 2014 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PG | MRK |
|---|---|---|
| Price | $149.61 | $119.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 17 |
| Target Price | ★ $163.64 | $125.59 |
| AVG Volume (30 Days) | 7.0M | ★ 7.8M |
| Earning Date | 04-24-2026 | 04-30-2026 |
| Dividend Yield | 2.89% | ★ 3.06% |
| EPS Growth | ★ 8.14 | 8.01 |
| EPS | ★ 5.36 | N/A |
| Revenue | ★ $84,284,000,000.00 | $65,011,000,000.00 |
| Revenue This Year | $5.76 | $3.61 |
| Revenue Next Year | $2.57 | $5.41 |
| P/E Ratio | $27.70 | ★ N/A |
| Revenue Growth | 0.29 | ★ 1.31 |
| 52 Week Low | $137.62 | $76.66 |
| 52 Week High | $166.90 | $125.14 |
Technical Indicators
Market Signals| Indicator | PG | MRK |
|---|---|---|
| Relative Strength Index (RSI) | 59.35 | 55.45 |
| Support Level | $139.96 | $112.96 |
| Resistance Level | $152.77 | $123.93 |
| Average True Range (ATR) | 2.98 | 2.89 |
| MACD | 0.85 | 0.22 |
| Stochastic Oscillator | 89.89 | 56.59 |
Price Performance
Historical ComparisonAbout PG Procter & Gamble Company (The)
Since its founding in 1837, Procter & Gamble has become one of the world's largest consumer product manufacturers, with annual sales of nearly $85 billion. It operates with a lineup of leading brands, including more than 20 that generate annual global sales of more than $1 billion each, such as Tide laundry detergent, Charmin toilet paper, Pantene shampoo, and Pampers diapers. Sales outside its home turf represent just more than half of the firm's consolidated total.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).